The trademark ProtectLIND was filed by PROPHYMED GmbH, a corporation established under the laws of the Federal Republic of Germany (the "Applicant"). The application was published for oppositions on November 15, 2022, and received one opposition filed on February 14, 2023 by Novartis AG on Likelihood of confusion. the opponent was represented by Nordemann Czychowski & Partner Rechtsanwältinnen und Rechtsanwälte mbB and proceedings were handled in English, and the oppositon was dismissed by the Euorpean Union Intellectual Property Office with decision issued February 14, 2023
The application was filed in German, and German was also language of all opposition proceedings (English was selected as the second language).